Are the release characteristics of Erzhi pills in line with traditional Chinese medicine theory? A quantitative study

Ekor, 2014, The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety, Front Pharmacol, 4, 177, 10.3389/fphar.2013.00177 Tang, 2008, Traditional Chinese medicine, Lancet, 372, 1938, 10.1016/S0140-6736(08)61354-9 Liu, 2015, Methodology guideline for clinical studies investigating traditional Chinese medicine and integrative medicine, Complement Ther Med, 23, 751, 10.1016/j.ctim.2015.08.001 Liu, 2016, Quality evaluation of Shenmaidihuang Pills based on the chromatographic fingerprints and simultaneous determination of seven bioactive constituents, J Sep Sci, 39, 4557, 10.1002/jssc.201600718 Chinese Pharmacopeia Commission. Pharmacopoeia of the People’s Republic of China. 2015th ed. Beijing: China Medical Science Press; 2015 [Chinese]. Zhang Z, Gao T, Fu C, Zhang J, Shi J, He Y, et al. Analysis on dosage form theory and current application situation of traditional Chinese medicine pill. Zhongguo Zhong Yao Za Zhi 2017; 42: 2408–12 [Chinese with abstract in English]. Chinese Pharmacopeia Commission. Erzhi Pills. In: Pharmacopoeia of the People’s Republic of China, 2015th ed. Beijing: China Medical Science Press; 2015: 758 [Chinese]. Xu, 2012, Er Zhi Wan, an ancient herbal decoction for woman menopausal syndrome, activates the estrogenic response in cultured MCF-7 cells: an evaluation of compatibility in defining the optimized preparation method, J Ethnopharmacol, 143, 109, 10.1016/j.jep.2012.06.009 Chen, 2011, Prescription patterns of Chinese herbal products for menopausal syndrome: analysis of a nationwide prescription database, J Ethnopharmacol, 137, 1261, 10.1016/j.jep.2011.07.053 Cao, 2020, Analysis of five active ingredients of Er-Zhi-Wan, a traditional Chinese medicine water-honeyed pill, using the biopharmaceutics classification system, Biomed Chromatogr, 34, 10.1002/bmc.4757 Zheng P, An D, Ji G. Effect of Chinese medicine complex prescriptions of different cure laws on PAI-1 mRNA of cholestasis-induced liver fibrosis rat. Zhong Xi Yi Jie He Gan Bing Za Zhi 2007;17(5):284–7 [Chinese with abstract in English]. Zhou LS, Ding K. Effect of anti-aging function of Erzhiwan on the immune organ and brain cell of senile rats. Xian Dai Yu Fang Yi Xue 2008;35(4):782–3, 787 [Chinese with abstract in English]. Zhong L. Premature ovarian failure (24 cases) treated with replenishing the kidney and promoting blood circulation to dissipate stasis method. Shi Yong Zhong Yi Za Zhi 2006;22(11):675 [Chinese]. Ding Y, Ma F, Shang X. Effect of Erzhiwan on anti-oxidation of skin tissue in aged mice resulting from D-galactose. Zhongguo Lin Chuang Kang Fu 2006;10(19):141–3 [Chinese with abstract in English]. Yao G, He Z. Study of active components with immunoregulation from Erzhi Pill on lymphocytes and macrophages in mice. Shi Zhen Guo Yi Guo Yao 2006;17(10):1921–3 [Chinese with abstract in English]. Disch, 2017, Dissolution testing of herbal medicines: challenges and regulatory standards in Europe, the United States, Canada, and Asia, Dissolution Technol, 24, 6, 10.14227/DT240217P6 Löbenberg, 2000, Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards, Eur J Pharm Biopharm, 50, 3, 10.1016/S0939-6411(00)00091-6 Zuo, 2014, Challenges and opportunities to use biowaivers to compare generics in China, AAPS PharmSciTech, 15, 1070, 10.1208/s12249-014-0133-8 United States Pharmacopeial Convention. National formula. United States Pharmacopiea. USP 41-NF36. Rockville: United States Pharmacopeial Convention; 2018: 6459–69. United States Pharmacopeial Convention. Buffer solutions. United States Pharmacopiea. USP 41-NF36. Rockville: United States Pharmacopeial Convention; 2018: 5748–50. Zuo, 2014, Evaluation of the DDSolver software applications, Biomed Res Int, 2014, 10.1155/2014/204925 Zhang, 2010, DDSolver: an add-in program for modeling and comparison of drug dissolution profiles, AAPS J, 12, 263, 10.1208/s12248-010-9185-1 Yin, 2013, Quantification of swelling and erosion in the controlled release of a poorly water-soluble drug using synchrotron X-ray computed microtomography, AAPS J, 15, 1025, 10.1208/s12248-013-9498-y Nam, 2019, Double controlled release of highly insoluble cilostazol using surfactant-driven pH-dependent and pH-independent polymeric blends and in vivo bioavailability in beagle dogs, Int J Pharm, 558, 284, 10.1016/j.ijpharm.2019.01.004 Costa, 2001, Modeling and comparison of dissolution profiles, Eur J Pharm Sci, 13, 123, 10.1016/S0928-0987(01)00095-1 Korsmeyer, 1983, Mechanisms of solute release from porous hydrophilic polymers, Int J Pharm, 15, 25, 10.1016/0378-5173(83)90064-9 Waldmann, 2012, Provisional biopharmaceutical classification of some common herbs used in Western medicine, Mol Pharm, 9, 815, 10.1021/mp200162b Govindachari T, Nagarajan K, Pai B. Wedelolactone from Eclipta alba. J Sci Ind Res 1956; 15B: 664–5 [Indian]. Han, 2015, Qualitative and quantitative analysis of Eclipta prostrata L. by LC/MS, ScientificWorldJournal, 2015, 10.1155/2015/980890 Wang, 2015, Comparative in vitro dissolution of two commercially available Er-Zhi-Wan herbal medicinal products, Indian J Pharm Sci, 77, 391, 10.4103/0250-474X.164774 Wang, 2014, Stability-indicating method of specnuezhenide in bulk drug and its kinetics and mechanisms of dedradation in queous solutions, Yao Yong Zhi Wu Yan Jiu, 5, 13 Grimm, 2018, Interindividual and intraindividual variability of fasted state gastric fluid volume and gastric emptying of water, Eur J Pharm Biopharm, 127, 309, 10.1016/j.ejpb.2018.03.002 Makoid, 1993, Modeling of dissolution behavior of controlled release systems, STP Pharma Prat, 3, 49 Puga, 2012, Hot melt poly-ε-caprolactone/poloxamine implantable matrices for sustained delivery of ciprofloxacin, Acta Biomater, 8, 1507, 10.1016/j.actbio.2011.12.020 Li X, Liu R. Debate on “Pill, is sluggish”. Zhongguo Yao Fang 2008;18(24):1917–9 [Chinese]. Li YH, Xiao J, Cai P, Peng Y, Wang Y, Zhang SH. Effects of superfine pulverization technology on the dissolution of Erzhi pill. Guo Ji Yao Xue Yan Jiu Za Zhi 2015;42(5):654–7 [Chinese with abstract in English]. Chen T, Kang B. Characteristic exploration of slow release preparations in traditional Chinese medicine pills. Zhongguo Yao Ye 2009;18(11):17–9 [Chinese with abstract in English]. Bian Y, Liang H, Liu X. Study on the extraction and stability of fatty oil in Ligustrum Lucidum ait. Shi Zhen Guo Yi Guo Yao 2007;18(11):2726–7 [Chinese with abstract in English]. Lin W, Liu J, Chen Z. The optimum preparation procedure for the extracting polyhexose contained in Ligustrum licidum Ait. fruit and composition analysis of its seeds oil. Fujian Shi Fan Da Xue Xue Bao 2003;19(1):81–5 [Chinese with abstract in English]. Jensen, 2013, Physical limits to leaf size in tall trees, Phys Rev Lett, 110, 10.1103/PhysRevLett.110.018104